Clinical

Dataset Information

0

CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions for CEA-Expressing Liver Metastases or Pancreas Cancer


ABSTRACT: This is an open label, fixed dose, phase Ib trial of anti-CEA CAR-T cell infusions delivered via the hepatic artery or splenic vein using the Surefire Infusion System (SIS) for patients with CEA-expressing liver metastases or pancreas cancer.

DISEASE(S): Neoplasm Metastasis,Liver Metastases,Gastric Cancer,Colorectal Cancer,Liver Neoplasms,Pancreatic Neoplasms,Breast Cancer

PROVIDER: 2221147 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2285031 | ecrin-mdr-crc
| 2187897 | ecrin-mdr-crc
2015-08-27 | E-GEOD-72398 | biostudies-arrayexpress
2023-02-03 | GSE213828 | GEO
2020-04-06 | GSE121888 | GEO
2019-10-31 | E-MTAB-7989 | biostudies-arrayexpress
2013-07-20 | E-GEOD-49040 | biostudies-arrayexpress
2020-10-29 | GSE155887 | GEO
2018-12-26 | GSE95154 | GEO
2013-07-20 | GSE49040 | GEO